IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $89,764,000 | -47.1% | 3,787,500 | -35.7% | 1.02% | -42.3% |
| Q2 2016 | $169,655,000 | -21.8% | 5,886,700 | -13.1% | 1.77% | -22.5% |
| Q1 2016 | $216,971,000 | -23.9% | 6,776,100 | +1.7% | 2.28% | -11.5% |
| Q4 2015 | $284,957,000 | +21.4% | 6,664,100 | 0.0% | 2.58% | +8.9% |
| Q3 2015 | $234,643,000 | -25.8% | 6,664,100 | -3.3% | 2.37% | +2.0% |
| Q2 2015 | $316,352,000 | -0.4% | 6,889,200 | +1.6% | 2.32% | -14.4% |
| Q1 2015 | $317,685,000 | +46.9% | 6,778,000 | -0.7% | 2.71% | +31.2% |
| Q4 2014 | $216,311,000 | +37.1% | 6,828,000 | +2.6% | 2.07% | +25.4% |
| Q3 2014 | $157,795,000 | -2.8% | 6,655,200 | +22.9% | 1.65% | -13.6% |
| Q2 2014 | $162,414,000 | +15.0% | 5,415,600 | +1.3% | 1.91% | +9.8% |
| Q1 2014 | $141,231,000 | +32.6% | 5,345,600 | +26.1% | 1.74% | +10.9% |
| Q4 2013 | $106,533,000 | +58.4% | 4,237,600 | +29.0% | 1.57% | +30.5% |
| Q3 2013 | $67,258,000 | +3.5% | 3,285,700 | +0.8% | 1.20% | -12.9% |
| Q2 2013 | $65,010,000 | – | 3,260,600 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
| Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
| Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
| SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
| Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
| Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
| Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
| Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
| Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
| Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |